A new clinical trial has been announced which aims to treat genetic hair loss in men with a nanofat grafting technique.
Researchers from Jinan University Guangzhou in China will recruit 10 participants with Male Pattern Baldness on which to study this method over a 12 month period.
What is nanofat grafting for hair loss?
Nanofat grafting involves tiny injections of autologous fat being administered to the area being treated.
Whilst the specific process to be used in this study has not been detailed, nanofat is usually obtained by harvesting body fat (adipose) via liposuction from the hip, stomach or buttock areas of the patient. It is then processed and filtered into a highly concentrated stem cell-rich solution. This is then injected back into their body where needed. In this case, this would be the top of the scalp and hairline as these are the only areas of the head affected by Male Pattern Hair Loss.
It can be used in cosmetic procedures for skin rejuvenation and now, Chinese investigators hope to prove its usefulness in relation to treating hairloss.
According to the Jinan University trial registration, each of the 10 men taking part will be aged between 18 and 50 years old. Those with scars, wounds or skin conditions affecting the scalp and those taking anticoagulant drugs are excluded, as are those with serious heart, liver, kidney or blood diseases.
The final participants are due to start treatment with processed nanofat grafting on 1st June 2018. Their progress will be monitored at the month 1, 3, 6, 9 and 12 marks, using dermatoscopy and self-assessment. Researchers will then compare the appearance of the hair follicles’ density and the hairs’ diameter before the procedure and then at the various intervals throughout the trial. The trial’s estimated end date is currently 1st June 2020.
Scalp injection trend
This is not the only study investigating the use of adipose-related hair loss treatments; Kerastem has been conducting various trials for a number of years now and was recently granted a patent in the USA, whilst another new study in Lebanon was announced in March 2018.
Injectable hair loss solutions seem to be forming something of a trend, with procedures such as Platelet Rich Plasma (PRP) therapy and Mesotherapy becoming popular, despite a lack of proven efficacy in treating genetic hair loss in men or women.
There are, however, existing hair loss treatments which have been clinically-proven, MHRA licensed and FDA approved. Medically-suitable men aged 18 and over have both oral and topical medication options, developed to encourage hair growth and, with on-going use, prevent baldness.
At Belgravia these are often combined with additional supporting products to maximise the hair’s health and potential – from Hair Vitalics for Men, highly-targeted premium food supplements, to FDA-cleared low-level laser devices used at home a few times per week to stimulate the follicles. This approach is incredibly popular due to its ease and efficacy, as well as the privacy it offers those dealing with the sensitive subject of men’s hair loss.
Whilst scalp injections may be trendy right now, their efficacy remains to be seen but this is an area we are watching with interest.
The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.